Bank of New York Mellon’s Cogentix Medical, Inc. CGNT Stock Holding History

Bank of New York Mellon’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-33,907	Closed	-$131K	–	4412
2018 Q1	$131K	Buy	33,907 +19,260	+131%	+$60.3K	﹤0.01%	4009
2017 Q4	$46K	Hold	14,647	–	–	﹤0.01%	4216
2017 Q3	$37K	Hold	14,647	–	–	﹤0.01%	4152
2017 Q2	$25K	Sell	14,647 -23,326	-61%	-$40K	﹤0.01%	4214
2017 Q1	$68K	Buy	37,973 +23,327	+159%	+$46.1K	﹤0.01%	4101
2016 Q4	$29K	Buy	14,646 +640	+5%	+$1.31K	﹤0.01%	4185
2016 Q3	$25K	Sell	14,006 -2,552	-15%	-$3.3K	﹤0.01%	4205
2016 Q2	$16K	Hold	16,558	–	–	﹤0.01%	4280
2016 Q1	$18K	Hold	16,558	–	–	﹤0.01%	4175
2015 Q4	$21K	Hold	16,558	–	–	﹤0.01%	4276
2015 Q3	$21K	Hold	16,558	–	–	﹤0.01%	4320
2015 Q2	$27K	Buy	+16,558	New	+$27.1K	﹤0.01%	4209

Bank of New York Mellon's CGNT Position: Q2 2018 in Review

Bank of New York Mellon sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 33,907 shares — an estimated $131K sold.

Bank of New York Mellon first reported a position in CGNT in Q2 2015 and held it in 12 quarters. The position peaked at $131K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Bank of New York Mellon reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Bank of New York Mellon sold 33,907 Cogentix Medical, Inc. shares in Q2 2018, an estimated $131K.
Bank of New York Mellon first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 12 quarters.
Bank of New York Mellon's Cogentix Medical, Inc. position peaked at $131K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.